Renal Denervation Device Market to Grow Dramatically, but Physicians Will Still Consider Cost-Effective Tradeoffs When Making Purchase Decisions
08:00 EDT 16 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
According to Millennium Research Group (MRG), the global authority on
medical technology market intelligence, renal denervation, a promising
new treatment for drug-resistant uncontrolled hypertension, has the
potential to be a b...
Other Sources for this Article
Decision Resources, Inc.
Christopher Comfort, 781-993-2597
ccomfort@dresources.com
or
Millennium
Research Group
Alex Jablokow, 617-599-8613
ajablokow@mrg.net
More From BioPortfolio on "Renal Denervation Device Market to Grow Dramatically, but Physicians Will Still Consider Cost-Effective Tradeoffs When Making Purchase Decisions"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
